Intersouth Partners is a venture capital firm that specializes in providing early-stage financing to healthcare, information technology, and biotechnology companies. The firm invests in innovative startups and helps them grow through strategic partnerships and management support.

Intersouth is an early-stage venture capital firm that invests in technology and life science companies across the Southeast.  Founded in 1985, Intersouth manages $780 million in seven venture capital limited partnerships, making it the largest venture capital fund in North Carolina and one of the largest in the Southeast.

We believe Intersouth brings a unique perspective to the venture capital process. Our team’s experience ranges from performing clinical research to managing institutional investment funds to creating and growing venture-backed companies to running multinational corporations. With experience across industries including venture capital, legal, medical, engineering and corporate finance, Intersouth’s team is positioned to help start-up ventures grow into successful companies.

Asensus Surgical

Viamet Pharmaceuticals

Clarabridge

PeopleMatter

Proteon Therapeutics

Lyra Therapeutics

MaxCyte

Alimera Sciences

AGTC

MicroCHIPS

Argos Therapeutics

Intersouth Partners

COM:INTERSOUTH

Intersouth Partners

Analysis Not Available